ESRP2
Basic information
Region (hg38): 16:68229033-68238102
Previous symbols: [ "RBM35B" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (99 variants)
- ESRP2-related_disorder (21 variants)
- Cleft_lip_with_or_without_cleft_palate (5 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ESRP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024939.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | |||||
| missense | 100 | 106 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 2 | 100 | 9 | 6 |
Highest pathogenic variant AF is 0.000013011072
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ESRP2 | protein_coding | protein_coding | ENST00000473183 | 15 | 8992 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.33e-7 | 0.999 | 125680 | 0 | 68 | 125748 | 0.000270 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.824 | 400 | 449 | 0.891 | 0.0000278 | 4535 |
| Missense in Polyphen | 167 | 196.07 | 0.85175 | 2034 | ||
| Synonymous | 1.37 | 166 | 190 | 0.874 | 0.0000118 | 1593 |
| Loss of Function | 2.90 | 17 | 35.7 | 0.476 | 0.00000204 | 363 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000603 | 0.000603 |
| Ashkenazi Jewish | 0.000199 | 0.000198 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.000832 | 0.000786 |
| European (Non-Finnish) | 0.000265 | 0.000264 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.0000795 | 0.0000653 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: mRNA splicing factor that regulates the formation of epithelial cell-specific isoforms. Specifically regulates the expression of FGFR2-IIIb, an epithelial cell-specific isoform of FGFR2. Also regulates the splicing of CD44, CTNND1, ENAH, 3 transcripts that undergo changes in splicing during the epithelial-to-mesenchymal transition (EMT). Acts by directly binding specific sequences in mRNAs. Binds the GU-rich sequence motifs in the ISE/ISS-3, a cis-element regulatory region present in the mRNA of FGFR2. {ECO:0000269|PubMed:19285943}.;
- Pathway
- FGFR2 alternative splicing;Signaling by FGFR2;Signal Transduction;Signaling by FGFR;Signaling by Receptor Tyrosine Kinases
(Consensus)
Intolerance Scores
- loftool
- 0.741
- rvis_EVS
- -0.73
- rvis_percentile_EVS
- 14.14
Haploinsufficiency Scores
- pHI
- 0.876
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.556
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.138
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Esrp2
- Phenotype
- embryo phenotype; respiratory system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); limbs/digits/tail phenotype; digestive/alimentary phenotype; homeostasis/metabolism phenotype; renal/urinary system phenotype; skeleton phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype;
Gene ontology
- Biological process
- alternative mRNA splicing, via spliceosome;fibroblast growth factor receptor signaling pathway;regulation of RNA splicing;positive regulation of epithelial cell proliferation;epithelial tube branching involved in lung morphogenesis;branching involved in salivary gland morphogenesis
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- RNA binding;mRNA binding